Paris, France and Boston, MA – April 13, 2016

ENTEROME Bioscience SA, a pioneer in the development of pharmaceuticals and diagnostics based on the gut microbiome, announces that Pierre Bélichard, its Chief Executive Officer, will participate at the following conferences:

• FBR Healthcare Series: New Prescriptions: Innovation in the Treatment of Diseases and Infections, April 20^th, New York

Dr Belichard will participate in a panel entitled The Human Microbiome and Applications in Novel Therapeutics at 8:30 am EST.

• Guggenheim Securities Microbiome Day, April 21^th, New York

The conference will include members of the senior management team from leading microbiome companies, key opinion leaders and investors to discuss how the microbiome is being harnessed to develop novel therapies for a broad spectrum of medical conditions.

Download the press release (.pdf format)